Placebo to INTESTIFIX 001

DRUG2 trials

Sponsors

Goethe University Frankfurt, Fraunhofer Institute For Translational Medicine And Pharmacology ITMP

Conditions

Intestinal colonization with vancomycin-resistant enterococci (VRE)Recurrent urinary tract infections (rUTI)

Phase 2

Fecal microbiota transfer for the secondary prevention of recurrent urinary tract infections in premenopausal women: a phase II trial (FEMITRANS)

Not yet recruitingCTIS2025-520452-28-00

Goethe University FrankfurtRecurrent urinary tract infections (rUTI)

Target: 24Updated: 2026-01-07

Randomized Controlled Trial Assessing the Effectiveness and Safety of Fecal Microbiota Transfer for VRE Eradication in Immunocompromised Patients (EU CTR, Phase II) – VRE-ex

Not yet recruitingCTIS2026-525632-41-00

Fraunhofer Institute For Translational Medicine And Pharmacology ITMPIntestinal colonization with vancomycin-resistant enterococci (VRE)

Target: 42Updated: 2026-07-21